Drug recall · October 17, 2018
Amlodipine Besylate USP 10 mg Tablets recall
Why: Subpotent Drug: One lot of product does not meet the product specification for Assay test at 3 month long term stability condition.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Amlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa, India, Manufactured for: Cipla USA, Inc. 1560 Sawgrass Corporate Parkway, Suite 130, Sunrise FL 33323 UPC 369097128159, NDC 69097-128-15
- Lots / codes
Lot #: GG80218, Exp. 12/2019
- Quantity
- 2880 bottles
- Company
- InvaGen Pharmaceuticals, Inc., Hauppauge, NY
- Distribution
- Nationwide with the United States
- Initiated
- October 3, 2018 · Voluntary: Firm initiated
- Classified
- October 11, 2018
- Reported
- October 17, 2018
- Ended
- July 13, 2021
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Amlodipine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.